This inventor holds 1 USPTO granted patent. Top assignee: The Boots Company Plc. Active years: 1991.
Company Filing History:
Years Active: 1991
Title: The Innovations of Derek Whybrow
Derek Whybrow is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of depression. His work has led to the development of a unique process that showcases his innovative spirit and dedication to improving mental health treatments.
Latest Patents
Derek Whybrow holds a patent for a process related to the preparation of N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate. This non-hygroscopic material has potential applications as a pharmaceutical agent in the treatment of depression. His patent reflects his commitment to advancing medical science and providing new solutions for mental health challenges.
Career Highlights
Throughout his career, Derek has been associated with The Boots Company Plc, a well-respected organization in the pharmaceutical industry. His role at the company has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development efforts. His work has not only enhanced his professional reputation but has also positively impacted the lives of many individuals seeking treatment for depression.
Collaborations
Derek has worked alongside James Edward Jeffery, a fellow innovator in the field. Their collaboration has fostered an environment of creativity and innovation, leading to advancements in pharmaceutical processes and products.
Conclusion
Derek Whybrow's contributions to the field of pharmaceuticals, particularly in the treatment of depression, highlight his innovative approach and dedication to improving mental health solutions. His patent and work with The Boots Company Plc exemplify the impact that dedicated inventors can have on society.